| Arrhythmia Alliance Symposia 1 | On-demand | |
| Arrhythmia Alliance Symposia 2 - Emerging Technologies and New Practices in Cardiac Management | On-demand | |
| Year in Review 1 | On-demand | |
| Year in Review 2 | On-demand | |
| AF Association Symposia 1 - What do the new ESC AF guidelines really mean? | On-demand | |
| AF Association Symposia 2 – Ablation session | On-demand | |
| Ablate & Pace | On-demand | |
| What came from all the AF Anticoagulation Registries | On-demand | |
| Arrhythmias following Cardiac Surgery | On-demand | |
| Important New Information about DOAC Therapy for Atrial Fibrillation in Special Situations | On-demand | |
| EP Masterclass 1 | On-demand | |
| EP Masterclass 2 | On-demand | |
| Heart Failure: a modern approach in 2021 | On-demand | |
| Your Data in the National Audit - Latest Findings and Future Direction | On-demand | |
| Research Session | On-demand | |
| Hybrid AF therapies: new evidence for the most complex forms of AF | On-demand | |
| Exclusion of the LAA in rhythm control therapies | On-demand |
| Chair: Dr Fozia Ahmed | Manchester, UK | |||
|---|---|---|---|---|
| ORGANISATIONAL ISSUES | ||||
| Implications of national cardiology GIRFT report for CRM - is it realistic or aspirational (or delusional)? | Prof Nick Linker | Middlesbrough, UK | ||
| Device follow up 2021 - what is frequency of optimal device follow up | Dr John Paisey | Southampton, UK | ||
| Remote monitoring for all - implications and affordability for a bradycardia population | Ms Caroline Green | Manchester, UK | ||
| Should leadless pacemakers be new standard of care in bradycardia pacing - implications for UK practice: Present and future | Dr Chris Pepper | Leeds, UK | ||
| Chair: Dr Honey Thomas | Northumbria, UK | |||
| CHALLENGES IN CARDIAC PACING | ||||
| Cardiac pacing - His bundle, septal and LBBB pacing or keep it simple | Dr Paul Foley | Swindon, UK | ||
| Leadless CRT | Prof Aldo Rinaldi | London, UK | ||
| Device complications - how to minmise risk | Dr Honey Thomas | Northumbria, UK | ||
| Challenging device cases: Venoplasty tips and tricks | Dr Andrew Turley | Middlesbrough, UK | ||
| MRI and cardiac devices: Why is this still an issue? | Dr Martin Lowe | London, UK | ||
| Chair: Dr Guy Haywood | Plymouth, UK | |||
| MISCELLANEOUS | ||||
| ECG - practical tips and tricks for the non specialist | Dr Stephen Murray | Newcastle Upon Tyne, UK | ||
| Cardiac anatomy for CRM specialist | Prof Sabine Ernst | London, UK | ||
| Arrhythmias during pregnancy | Dr Dawn Adamson | Coventry, UK | ||
| Ventriuclar ectopy - when to worry and management options | Dr Guy Haywood | Plymouth, UK | ||
| Arrhythmias in athletes: What to do? | Dr David Begley | Cambridge, UK | ||
| Chair: | ||||
| ICD THERAPY | ||||
| Primary prevention ICD therapy - time for a rethink | Dr Andrew Flett | Southampton, UK | ||
| Dilated cardiomyopathy - what is OMT in 2021 | Dr Matthew Dewhurst | Stockton on Tees, UK | ||
| LV remodelling - when to decide on device therapy in DCM | Prof Roy Gardner | Glasgow, UK | ||
| Predicting SCD: Beyond EF | Prof Andre Ng | Leicester, UK | ||
| ATP or no ATP for primary prevention ICDs | Prof Neil Herring | Oxford, UK |
| Chair: Prof Dhiraj Gupta, Prof Tim Betts | Liverpool, UK, Oxford, UK | |||
|---|---|---|---|---|
| Pulsed field ablation of AF | Prof Pierre Jais | Bordeaux, FR | ||
| Advances in leadless pacing | Prof Vivek Reddy | New York, US | ||
| COVID-19 and remote monitoring - lessons for the future | Ms Cristiana Monteiro | Oxford, UK | ||
| Cardiac radiotherapy for VT | Prof Ross Hunter | London, UK | ||
| Sources and contemporary recordings of electrocardiograms | Professor Andrew Grace | Cambridge, UK | ||
| Laser ablation | Dr Scott Gall | Blackpool, UK |
| Chair: Dr Claire Martin | Cambridge, UK | |||
|---|---|---|---|---|
| Ventricular arrhythmia | Dr John Sapp | Halifax, CA | ||
| AF | Prof Jon Kalman | Melbourne, AU | ||
| What's on the horizon – the next 24-26 months | Dr Paul Zei | Boston, US |
| Chair: Prof Robert Sheldon | Calgary, CA | |||
|---|---|---|---|---|
| Bradycardia | Prof Kenneth Ellenbogen | Richmond, US | ||
| ICDs / CRT | Prof Andrew Epstein | Pennsylvania, US | ||
| Syncope | Prof Robert Sheldon | Calgary, CA |
| Chair: Prof Richard Schilling | London, UK | |||
|---|---|---|---|---|
| Should we adopt a comprehensive characterisation of AF patients | Prof Tatjana Potpara | Belgrade, RS | ||
| How much can AF be managed by adopting a healthy lifestyle? | Dr Prashanthan Sanders | Adelaide, AU | ||
| How do we pick rhythm control for our AF patients? | Prof Paulus Kirchhof | Hamburg, DE | ||
| How much can the AF patient be involved in making management decisions? | Dr Deirdre Lane | Liverpool, UK |
| Chair: Dr Derick Todd, Prof Tim Betts | Liverpool, UK, Oxford, UK | |||
|---|---|---|---|---|
| What QoL reduction related to AF is necessary to make ablation a worthwhile procedure and how do we measure it? | Dr Kim Rajappan | Oxford, UK | ||
| What should we do in addition to PVI for 1st time persistent AF – the posterior box or something else? | Prof Dhiraj Gupta | Liverpool, UK | ||
| How to judge when can we stop anticoagulants in post AF ablation when CHADSVASc>1 | Prof John Camm | London, UK | ||
| Should LAAO isolation & occlusion be part of treatment for persistent AF? | Dr Dhanunjaya Lakkireddy | Kansas, US | ||
| AF ablation to treat heart failure. Therapy or futility? | Prof Pier Lambiase | London, UK | ||
| Do better lesions mean better outcomes? Power, force or electroporation – what is the answer? | Prof Helmut Puererfellner | Linz, AT | ||
| How to define AF substrate: Voltage, velocities or late LGE and does it help guide ablation? | Prof Andre Ng | Leicester, UK | ||
| How to map atrial fibrillation and identify targets for ablation | Dr Tom Wong | London, UK | ||
| Chair: Dr Shouvik Haldar | London, UK | |||
| Debate: AF ablation as first line therapy - Pro | Dr Guy Haywood | Plymouth, UK | ||
| Debate: AF ablation as first line therapy - Con | Dr Hugh Calkins | Baltimore, US | ||
| Chair: Prof Andre Ng | Leicester, UK | |||
| Debate: Cryo ablation should be the index ablation for all - Pro | Dr Jason Andrade | Vancouver, CA | ||
| Debate: Cryo ablation should be the index ablation for all - Con | Dr Damian Redfearn | Kingston, CA |
| Chair: Dr Alistair Slade, Prof Derek Connelly | Truro, UK, Glasgow, UK | |||
|---|---|---|---|---|
| Ablate & pace – the evidence | Dr Howard Marshall | Birmingham, UK | ||
| Patient selection – is it only for failed AF ablation and permanent AF? | Dr Claire Martin | Cambridge, UK | ||
| Which CRT patients need AV nodal ablation? And which AV nodal ablation patients need CRT? | Dr Archie Rao | Liverpool, UK | ||
| AV nodal ablation and His bundle pacing – who, how and why? | Prof Haran Burri | Geneva, CH | ||
| Programming issues – lower rate limit, mode switching, sensor issues | Mrs Eleri Gregory | Manchester, UK |
| Chair: Professor Lord Ajay Kakkar, Prof Bernard Gersh | London, UK, Rochester, US | |||
|---|---|---|---|---|
| GLORIA | Prof Gregory Lip | Liverpool, UK | ||
| GARFIELD | Prof Jean-Pierre Bassand | Besançon, FR | ||
| ORBIT | Dr Jonathan Piccini | Durham, US | ||
| PREFER IN AF | Dr Ameet Bakhai | London, UK |
| Chair: Dr Niall Campbell | Manchester, UK | |||
|---|---|---|---|---|
| Risk stratification using risk scores - where are we now? | Prof Benjamin O'Brien | Berlin, DE | ||
| Post operative AF - who, how and how to prevent | Prof Bernard Gersh | Rochester, US |
| Chair: Prof Gregory Lip, Prof John Camm | Liverpool, UK, London, UK | |||
|---|---|---|---|---|
| 2021 EHRA practical NOAC guide for AF (new edition) | Prof Jan Steffel | Zurich, CH | ||
| AF, dementia and oral anticoagulation | Prof Tatjana Potpara | Belgrade, RS | ||
| AF, diabetes mellitus and oral anticoagulant | Prof Laurent Fauchier | Tours, FR | ||
| AF, chronic kidney disease and oral anticoagulants | Prof Reinhold Kreutz | Berlin, DE |
| Chair: Mr Ian Wright | London, UK | |||
|---|---|---|---|---|
| When you don't need an EP study to know the diagnosis | Dr Andreas Kyriacou | Sheffield, UK | ||
| The origin of the different pacing manoeuvres we use in EP | Mr Aaron Sreenivasan | London, UK | ||
| When it's easy to get the diagnosis wrong | Prof Sabine Ernst | London, UK | ||
| Focal or re-entrant? Response to entrainment and other clues | Dr Nick Linton | London, UK |
| Chair: Dr Ashley Nisbet | Bristol, UK | |||
|---|---|---|---|---|
| Ablation from the aortic root: ATs, VTs and pathways | Dr David Lefroy | London, UK | ||
| Protecting the phrenic nerve during ablation | Dr John Silberbauer | Brighton, UK | ||
| Mapping and ablation of papillary muscle VEs | Dr Usha Tedrow | Boston, US | ||
| High power RF ablation: The way forward? | Prof Andre Ng | Leicester, UK |
| Chair: Mrs Carys Barton, Prof Martin Cowie | London, UK, London, UK | |||
|---|---|---|---|---|
| What's new in the ESC HF2021 guideline: Diagnosis | Prof Roy Gardner | Glasgow, UK | ||
| What's new in the ESC HF2021 guideline: Treatment | Prof Theresa McDonagh | London, UK | ||
| Atrial fibrillation and HF: Do we know what we should do? | Prof Dipak Kotecha | Birmingham, UK | ||
| ICDs for patients with heart failure: do we still need them? | Dr Jonathan Behar | London, UK |
| Chair: Dr Alistair Slade, Dr Ashley Nisbet | Truro, UK, Bristol, UK | |||
|---|---|---|---|---|
| National audit of CRM devices and ablation: key findings from the latest report | Dr Francis Murgatroyd | London, UK | ||
| Patient reported outcomes in CRM – what’s coming? | Dr Ashley Nisbet | Bristol, UK | ||
| Use of national registry for device surveillance | Dr Mark Dayer | Taunton, UK | ||
| What can NICOR do for your centre? New online tools for you to check your data and benchmark your centre | Mrs Sue Manuel | London, UK | ||
| How can our CRM audit data be used by the NHS in the future? Linkage with other sources to improve outcomes? | Prof Nick Linker | Middlesbrough, UK |
| Chair: Prof Aldo Rinaldi, Prof Pier Lambiase | London, UK, London, UK | |||
|---|---|---|---|---|
| Lessons learned in designing and executing lean, cost-effective trials | Prof Mark Petrie | Glasgow, UK | ||
| How to do a meta-analysis and systematic review - the dos and the don'ts | Dr Rui Providencia | London, UK | ||
| What are the top tier journals looking for in an EP/Devices paper? | Prof Harry Crijns | Maastricht, NL | ||
| Public-patient involvement in research - how to do it | Dr Yang Chen | London, UK | ||
| Life as an Arrhythmia Research Nurse - a career worth considering? | Miss Genine Sambile, Dr Sophie Welch | London, UK, London, UK |
| Clinical data and outcomes | Dr Riyaz Kaba | London, UK | ||
| Optimal patient selection | Dr Syed Ahsan | London, UK |
| Thrombogenic and arrhythmogenic roles of the LAA | ||||
| Current options to electrically isolate the LAA | Dr Sandeep Panikker | Coventry, UK |